Peter Attia MD334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more
At a glance
WHAT IT’S REALLY ABOUT
Tom Dayspring and Peter Attia Explain ApoB, Lp(a), and Atherosclerosis
- Dayspring describes atherosclerosis as the deposition of cholesterol in the artery wall by apoB-containing particles, a process that begins in childhood or even in utero and takes decades to cause symptoms.
- Both speakers argue that apoB, which counts atherogenic particles, is the key marker to measure and lower, with triglycerides, non-HDL cholesterol, and Lp(a) adding information that apoB alone can miss.
- Insulin resistance and elevated triglycerides raise apoB by producing small, slowly cleared LDL and remnant particles, while HDL cholesterol is a poor guide to risk because HDL function can't be read from its cholesterol content.
- The discussion turns to the brain, where all cholesterol is made locally, astrocytes supply neurons through ApoE-carrying particles, and the ApoE4 protein is a dysfunctional carrier linked to Alzheimer's risk.
- On statins and the future, Dayspring proposes desmosterol as a possible biomarker of brain cholesterol synthesis, notes that trial data show no signal of statin-caused dementia, and favors low-dose statins combined with other apoB-lowering drugs.
IDEAS WORTH REMEMBERING
5 ideasAtherosclerosis is a slow process that starts very early in life.
Autopsy studies show fatty streaks in children and plaque beginning in fetuses of mothers with familial hypercholesterolemia, which supports primordial prevention and lipid testing in the pediatric age group.
ApoB is the key number because each atherogenic particle carries exactly one apoB molecule.
Measuring apoB counts the particles that can enter the artery wall, which is why Dayspring says it is the ball game and that apoB and triglycerides are all he needs to measure in blood.
Lp(a) is a small but highly dangerous inherited particle.
About 20% of people inherit it, Dayspring says it is seven to eight times more atherogenic per particle than LDL, and he says it should be checked once in life, though it can't yet be lowered directly.
Triglycerides above about 100 mg/dL signal trouble, mainly through their effect on apoB.
Dayspring explains that lipid exchange produces small LDL that clears poorly and raises remnants, so the goal of therapy is lowering apoB rather than just triglycerides, as the fibrate trials showed.
HDL cholesterol level tells you little about HDL function or personal risk.
Dayspring says HDL function depends on its proteins and phospholipids, not its cholesterol cargo, so a high HDL-C is not protection; Attia recounts a friend with high HDL-C who had a high calcium score.
WORDS WORTH SAVING
5 quotesWell, apoB is the ball game nowadays.
— Tom Dayspring
None of this happens, like you overeat a lot of cholesterol tonight and then, boy, next week you're, you're gonna have a heart attack. It takes decades.
— Tom Dayspring
Cholesterol is almost certainly the most important molecule in the brain.
— Tom Dayspring
So it's like the, the cr- not everybody's a criminal in our country, but it doesn't take a lot of criminals to cause a lot of havoc.
— Tom Dayspring
I can guarantee you it is not a declaration of cardiac immortality.
— Tom Dayspring
High quality AI-generated summary created from speaker-labeled transcript.
